1.

2.
Type 2 diabetes across generations: from pathophysiology to prevention and management
by Nolan, Christopher J, Assoc Prof
The Lancet (British edition), 2011, Vol.378 (9786), p.169-181

3.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094

4.
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
by Bellamy, Leanne, MBBS
The Lancet (British edition), 2009, Vol.373 (9677), p.1773-1779

5.
Periodontitis and diabetes: a two-way relationship
by Preshaw, P. M
Diabetologia, 2011, Vol.55 (1), p.21-31

6.
Molecular mechanisms of diabetic cardiomyopathy
by Bugger, Heiko
Diabetologia, 2014, Vol.57 (4), p.660-671

7.
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
by Kahn, Steven E, Prof
The Lancet (British edition), 2014, Vol.383 (9922), p.1068-1083

8.
Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies
by Aune, Dagfinn
European journal of epidemiology, 2013, Vol.28 (11), p.845-858

9.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
by Ray, Kausik K, Dr
The Lancet (British edition), 2009, Vol.373 (9677), p.1765-1772

10.
The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities
by Schram, M.T
European journal of epidemiology, 2014, Vol.29 (6), p.439-451

11.
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
by Broekhuizen, L. N
Diabetologia, 2010, Vol.53 (12), p.2646-2655

12.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised...
by Griffin, Simon J, Dr
The Lancet (British edition), 2011, Vol.378 (9786), p.156-167

13.
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
by Lim, E. L
Diabetologia, 2011, Vol.54 (10), p.2506-2514

14.
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
by Tabák, Adam G, Dr
The Lancet (British edition), 2009, Vol.373 (9682), p.2215-2221

15.

16.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014, Vol.57 (12), p.2465-2474

17.
Type 2 diabetes: principles of pathogenesis and therapy
by Stumvoll, Michael
The Lancet (British edition), 2005, Vol.365 (9467), p.1333-1346

18.
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
by Lavalle-González, F. J
Diabetologia, 2013, Vol.56 (12), p.2582-2592

19.
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health
by Henson, J
Diabetologia, 2013, Vol.56 (5), p.1012-1020

20.
